CN1800133A - Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal - Google Patents

Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal Download PDF

Info

Publication number
CN1800133A
CN1800133A CN 200610017380 CN200610017380A CN1800133A CN 1800133 A CN1800133 A CN 1800133A CN 200610017380 CN200610017380 CN 200610017380 CN 200610017380 A CN200610017380 A CN 200610017380A CN 1800133 A CN1800133 A CN 1800133A
Authority
CN
China
Prior art keywords
dihydroxyanthraquinone
radix rubiae
charred radix
preparation
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200610017380
Other languages
Chinese (zh)
Other versions
CN100408535C (en
Inventor
张振凌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bozhou Huqiao Pharmaceutical Co., Ltd.
Original Assignee
Henan University of Traditional Chinese Medicine HUTCM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan University of Traditional Chinese Medicine HUTCM filed Critical Henan University of Traditional Chinese Medicine HUTCM
Priority to CNB2006100173805A priority Critical patent/CN100408535C/en
Publication of CN1800133A publication Critical patent/CN1800133A/en
Application granted granted Critical
Publication of CN100408535C publication Critical patent/CN100408535C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a method for extracting styptic matter 1, 3-alizarin from the gamene wood coal. It heats the gamene medical herb to prepare it into gamene wood coal with the high effect liquid phase testing 1, 3-alizarin content above 0.15%; it then disposes the gamene wood coal powder in the carbinol to do supersonic and filter to obtain the filter liquid which obtains the volatile substance after filter liquid volatilizing; it adds water to dissolve it and dose ether extraction, uses silica gel column to wash, prepares the liquid phase separation and condensation drying to obtain the 1, 3-alizarin.

Description

From charred RADIX RUBIAE, extract hemostatic substance 1, the preparation method of 3-dihydroxyanthraquinone
One, technical field
The present invention relates to a kind of hemostatic substance 1, preparation method of 3-dihydroxyanthraquinone of extracting from charred RADIX RUBIAE.
Two, background technology
Madder is the dry root and rhizome of madder wort madder Rubia cordifolia L-.With Shaanxi, Henan and Shanxi are the main producing region, are consistent with " to the west of many and good ".In addition in Shandong, ground such as northeast, Sichuan, Yunnan, Guizhou, all have root and rhizome that long medicinal history is arranged in the locality with congener, be clinical conventional Chinese medicine.Madder has cooling blood for hemostasis, and the effect that the stasis of blood of dispelling is stimulated the menstrual flow cures mainly haematemesis, bleeding from five sense organs or subcutaneous tissue, metrostaxis, and traumatic hemorrhage is through closing stasis of blood resistance, arthralgia, tumbling and swelling.Clinical Chang Shengyong and stir-fry charcoal are used.Why charred RADIX RUBIAE can stop blooding, hemostatic substance could be prepared from charred RADIX RUBIAE more fully to be used for hemostasis, it is the problem that medical matters circle are concerned about very much always, find after deliberation, why charred RADIX RUBIAE can stop blooding is because charred RADIX RUBIAE contains a kind of 1, the hemostatic substance of 3-dihydroxyanthraquinone, could be with 1, the 3-dihydroxyanthraquinone extracts from madder, to improve medicinal effect? in order to study to the charred RADIX RUBIAE hemostasis is further, improve preparation technology and understand before and after the process of preparing Chinese medicine and pharmacological action, for this reason, the further development and use of charred RADIX RUBIAE being listed in country's 15 tackling of key scientific and technical problems problems studies.
Three, summary of the invention
Tackling key problem requires and the hematostatic actual needs at national science and technology, the present invention's purpose just provides a kind of hemostatic substance 1 that extracts from charred RADIX RUBIAE, the preparation method of 3-dihydroxyanthraquinone, can effectively solve preparation hemostatic substance 1 from charred RADIX RUBIAE, the problem of 3-dihydroxyanthraquinone, the technical scheme of its solution are that the gamene decoction piece heating is concocted and become charred RADIX RUBIAE, high-efficient liquid phase technique detects 1, the content of 3-dihydroxyanthraquinone must not be lower than 0.15%, and it is ultrasonic to place methyl alcohol to carry out the charred RADIX RUBIAE meal then, filters to get filtrate, after doing, the filtrate volatilization gets volatile matter, be dissolved in water, extracted with diethyl ether is used the silicagel column wash-out again, the preparation liquid phase separation, concentrate drying is 1, the 3-dihydroxyanthraquinone, and the inventive method is simple, easy handling, can be effective to deep processing, improve the pharmaceutical use of madder, also open up new prospect for the hemostasis medication to madder, it is succeeded in developing, and is the creative contribution to Chinese materia medica.
Four, embodiment
Below in conjunction with practical situation the specific embodiment of the present invention is elaborated.
Provide by technique scheme, the present invention is, at first madder is cut into the sheet of 0.2-0.5cm, 200-228 ℃ fry down 8-12min (minute) make it the surface and be burnt brown, inner coke yellow becomes the charred RADIX RUBIAE medicine materical crude slice, the charred RADIX RUBIAE medicine materical crude slice is detected by high-efficient liquid phase technique, in its medicine materical crude slice 1, and the content of 3-dihydroxyanthraquinone 〉=0.15% (promptly must not be lower than 0.15%), then the charred RADIX RUBIAE medicine materical crude slice is pulverized, with every 100g place carry out in the methyl alcohol 500ml ultrasonic 30min (minute), filter, after volatilizing, add water 100ml dissolving, the ether position is collected in ether 500ml extraction 3 times, concentrates, silicagel column is used sherwood oil successively: ethyl acetate was with 100: 1,50: 1,30: 1,10: 1 mixed solution carries out wash-out, collect 10: 1 elutriants, concentrate, the preparation liquid phase is done moving phase with methanol-water, the ratio of first alcohol and water is 7.6: 2.4, flow velocity 10ml/min collects corresponding flow, concentrates, dry, promptly get 1,3-dihydroxyanthraquinone yellow crystal, its molecular structural formula is:
Optimum implementation of the present invention is, at first madder is cut into the sheet of 0.4cm, gets charred RADIX RUBIAE medicine materical crude slice 2kg, put in the electric heating machine for stir-frying Chinese medicine 220 ℃ of controlled temperature, heating 10min takes out and pulverizes, it is 0.21% that the high-efficient phase chromatogram method is measured content, places with every 100g and carries out ultrasonic 30 minutes in the methyl alcohol 500ml, filters, after volatilizing, add water 100ml dissolving, the ether position is collected in ether 500ml extraction 3 times, concentrate, silicagel column is used sherwood oil successively: ethyl acetate was with 100: 1,50: 1,30: 1,10: 1 mixed solution carries out wash-out, observes chromatographic column and thin layer and detects spot, collects 10: 1 elutriants, concentrate, through the preparation liquid phase, do moving phase with methanol-water, the ratio of first alcohol and water is 7.6: 2.4, flow velocity 10ml/min, flow when collecting 7 minutes concentrates drying, promptly get 1,3-dihydroxyanthraquinone yellow crystal.
Gained material of the present invention is 1 after measured, the 3-dihydroxyanthraquinone, be by a kind of medicinal novel substance that extracts in the charred RADIX RUBIAE, through animal and clinical trial, haemostatic effect is very good, is far superior to madder itself, and purposes is very extensive, and compare with other haemostatic medicaments outstanding superiority is also arranged, now relevant situation is described as follows:
One, gets 30 of mouse, male and female half and half, be divided into 3 groups at random, be respectively blank group, 1,3-dihydroxyanthraquinone, Yunnan white powder group, its empty group is given and physiological saline, all the other each group was given separately medicine 3 days,, disposable 20 μ l heparin tubes are inserted mouse endocanthion ball posterior vein get blood after one hour in the last administration, get full 20 μ l blood.Every 15 seconds the capillary vessel that fractures a bit of, check to have or not the blood clotting silk to occur that the meter record to the time that the trace of blood occurs, is the clotting time from blood sampling.Experimental result sees the following form.
1, the 3-dihydroxyanthraquinone is to the influence of clotting time of mice (x ± s)
Group Number of animals (only) Dosage (g/kg) Clotting time (min)
Blank group 10 - 5.98±0.99
The Yunnan white powder group 10 0.5 2.13±1.00 **
1,3-dihydroxyanthraquinone group 10 - 2.08±1.04 **
Annotate: compare with the blank group, *P<0.01.
During the experimental result table: 1, the 3-dihydroxyanthraquinone has the effect of tangible shortening clotting time of mice, and utmost point significance meaning (p<0.01) is arranged, results suggest 1, the 3-dihydroxyanthraquinone has tangible anastalsis.
Two, to the wound bleeding straightway testing
1, gets 10 of mouse, draw little stomatorrhagia with scalpel, with spreading on medicine of the present invention at shank, hemorrhage 1-2 promptly ended in second, and spread on the edge of a knife with the powder that former madder is made, and did not have obvious haemostatic effect, that is to say that the madder powder should not be directly used in wound, prepared product of the present invention is remarkably productive.
2, clinical in outpatient service and inpatient's 11 people's wound application, behind the application material of the present invention, 1-2 minute hemorrhage stops or obviously alleviates, and pain relief, has obtained gratifying effect.
In a word, of the present invention succeeding in developing, solved a difficult problem of madder tackling key problem, can be widely used in haematemesis, bleeding from five sense organs or subcutaneous tissue, metrostaxis, traumatic hemorrhage, hemorrhage through closing stasis of blood resistance, arthralgia and tumbling and swelling and causing by a variety of causes, combination with other components, can prepare various hemostasis good medicine, for development and use and the Chinese materia medica treasure-house of madder are made creative contribution.

Claims (2)

1, a kind of hemostatic substance 1 that from charred RADIX RUBIAE, extracts, the preparation method of 3-dihydroxyanthraquinone, it is characterized in that being, at first madder is cut into the sheet of 0.2-0.5cm, make it the surface at 200-228 ℃ of following stir-fry 8-12min and be burnt brown, inner coke yellow becomes the charred RADIX RUBIAE medicine materical crude slice, its medicine materical crude slice interior 1, the content of 3-dihydroxyanthraquinone 〉=0.15%, then the charred RADIX RUBIAE medicine materical crude slice is pulverized, placed with every 100g and carry out ultrasonic 30min in the methyl alcohol 500ml, filter, after volatilizing, add water 100ml dissolving, the ether position is collected in ether 500ml extraction 3 times, concentrate, silicagel column is used sherwood oil successively: ethyl acetate was with 100: 1,50: 1,30: 1,10: 1 mixed solution carries out wash-out, collects 10: 1 elutriants, concentrates, the preparation liquid phase is done moving phase with methanol-water, the ratio of first alcohol and water is 7.6: 2.4, and flow velocity 10ml/min collects corresponding flow, concentrate drying.
2, the hemostatic substance 1 that from charred RADIX RUBIAE, extracts according to claim 1, the preparation method of 3-dihydroxyanthraquinone is characterized in that, the said sheet that at first madder is cut into 0.4cm, get charred RADIX RUBIAE medicine materical crude slice 2kg, put in the electric heating machine for stir-frying Chinese medicine 220 ℃ of controlled temperature, heating 10min, take out and pulverize, it is 0.21% that the high-efficient phase chromatogram method is measured content, places with every 100g and carries out ultrasonic 30 minutes in the methyl alcohol 500ml, filters, after volatilizing, add water 100ml dissolving, the ether position is collected in ether 500ml extraction 3 times, concentrate, silicagel column is used sherwood oil successively: ethyl acetate was with 100: 1,50: 1,30: 1,10: 1 mixed solution carries out wash-out, observes chromatographic column and thin layer and detects spot, collects 10: 1 elutriants, concentrate, through the preparation liquid phase, do moving phase with methanol-water, the ratio of first alcohol and water is 7.6: 2.4, flow velocity 10ml/min, flow when collecting 7 minutes concentrates drying, promptly get 1,3-dihydroxyanthraquinone yellow crystal.
CNB2006100173805A 2006-01-25 2006-01-25 Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal Expired - Fee Related CN100408535C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100173805A CN100408535C (en) 2006-01-25 2006-01-25 Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100173805A CN100408535C (en) 2006-01-25 2006-01-25 Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal

Publications (2)

Publication Number Publication Date
CN1800133A true CN1800133A (en) 2006-07-12
CN100408535C CN100408535C (en) 2008-08-06

Family

ID=36810391

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100173805A Expired - Fee Related CN100408535C (en) 2006-01-25 2006-01-25 Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal

Country Status (1)

Country Link
CN (1) CN100408535C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101664462B (en) * 2008-09-04 2012-02-01 河南大学 Hypoglycemic active part and hypoglycemic effective component of madder, preparation method and application thereof
CN107807100A (en) * 2017-09-14 2018-03-16 广州中医药大学 A kind of method for building up and purification process of madder medicinal material Radix Rubiae total anthraquinones assay

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101664462B (en) * 2008-09-04 2012-02-01 河南大学 Hypoglycemic active part and hypoglycemic effective component of madder, preparation method and application thereof
CN107807100A (en) * 2017-09-14 2018-03-16 广州中医药大学 A kind of method for building up and purification process of madder medicinal material Radix Rubiae total anthraquinones assay

Also Published As

Publication number Publication date
CN100408535C (en) 2008-08-06

Similar Documents

Publication Publication Date Title
CN101862351B (en) Application of active parts of gallnut in preparing anti-ulcerative colitis medicine
CN101711805A (en) Medicine composition for treating rheumatoid arthritis and preparation thereof
CN100408535C (en) Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal
CN106309671B (en) Longnan of Gansu Province Z-bungeanum Maxim extract components and preparation method thereof and detection method
CN101181329A (en) Total chromocor extract of blumea riparia as well as pharmaceutical composition and preparing method thereof
CN101961376A (en) Method for refining sweet basil herb extract
CN101288762B (en) Content determination method of medicine composition for treating natal lochioschesis
CN103893412B (en) A kind of antitumor beautyberry extract and its production and use
CN1700927A (en) Pharmaceutical composition for treating menorrhagia and method for preparing the same
CN113712999B (en) Application of Zhuang medicine xue Dang dry paste powder in preparation of anti-inflammatory analgesic medicine
CN1961912B (en) Chinese medicinal composition having pain-easing bleeding-stopping functions
CN102048843B (en) Qingpeng emplastrum for reducing swelling and stopping pain and preparation method thereof
CN101288753B (en) Chinese medicinal composition for treating S hematuria and preparation method and quality control method thereof
CN104096150B (en) Stahlianthus hainanensis (Hayata) T. L. Wu and its extract are preparing treatment and/or the application of prevention cancer drug
CN100453070C (en) Aseptic dry powder spray agent and production method in use for stopping the blood and diminishing inflammation in wound
CN102579696B (en) Chinese herbal compound prescription for treating transfusion phlebophlogosis, method for preparing same and application of Chinese herbal compound prescription
CN102232982A (en) Extract product of herba cephalanoploris effective position, preparation method thereof and purpose thereof
CN109045089A (en) Instant bupleurum root dropping pills and preparation method thereof
CN101380356A (en) Tibetan medicine Duyiwei total flavone extract and extraction method and use thereof
CN109568474B (en) Preparation for treating aphtha and preparation method thereof
CN100444854C (en) Ointment for treating phlebitis and method for preparing same
CN103083523B (en) Traditional Chinese medicine composition for treating chronic prostatitis and preparation method of composition
CN106176775B (en) Forsythiaside B and poliumoside compatible composition and its application
CN104800756B (en) Expand Chinese prescription and preparation method that peripheral blood vessel improves PICC puncture success rates
CN100998651B (en) Medicine for treating thromboembolia type disease and its preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: ANHUI HUQIAO TRADITIONAL CHINESE MEDICINE TECHNOLO

Free format text: FORMER OWNER: HENAN TRADITIONAL CHINESE MEDICINE COLLEGE

Effective date: 20111130

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 450008 ZHENGZHOU, HENAN PROVINCE TO: 236800 BOZHOU, ANHUI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20111130

Address after: 236800 Private Industrial Park, Anhui, Bozhou

Patentee after: Anhui Huqiao Traditional Chinese Medicine Technology Co., Ltd.

Address before: 450008 No. 1 Jinshui Road, Henan, Zhengzhou

Patentee before: Henan University of Traditional Chinese Medicine

ASS Succession or assignment of patent right

Owner name: HAOZHOU HUQIAO PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: ANHUI HUQIAO TRADITIONAL CHINESE MEDICINE TECHNOLOGY CO., LTD.

Effective date: 20140319

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 236800 BOZHOU, ANHUI PROVINCE TO: 236000 BOZHOU, ANHUI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140319

Address after: 236000 Bozhou Industrial Park, Anhui

Patentee after: Bozhou Huqiao Pharmaceutical Co., Ltd.

Address before: 236800 Private Industrial Park, Anhui, Bozhou

Patentee before: Anhui Huqiao Traditional Chinese Medicine Technology Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080806

Termination date: 20150125

EXPY Termination of patent right or utility model